Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05860127 · ClinicalTrials.gov registry record · NA

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

A NA study, sponsored by University of Massachusetts, Amherst.

Completed
Registry status
NA
Development phase
133
Enrollment target

NCT05860127 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 133 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05860127, a NA study, has completed, sponsored by University of Massachusetts, Amherst.

COMPLETED
Registry status
NA
Development phase
133 participants
Enrollment target

Study Summary

Cognitive Stimulation Therapy (CST) is an evidence-based non-pharmacological group therapy shown to benefit people with mild to moderate dementia. Despite increasing availability of CST worldwide, access remains limited in the United States. This pilot pragmatic trial will embed CST referral into the standard care protocol of health care settings that serve people living with dementia in the state of Connecticut, and evaluate online delivery of CST known as virtual CST (V-CST), and assess the acceptability of V-CST to people living with dementia. The study design is a two-armed randomized embedded pragmatic clinical trial (ePCT). The trial aims to determine if cognitive decline is experienced less commonly among V-CST participants than control group members based on three widely used measures of cognition, the Montreal Cognitive Assessment (MoCA), St. Louis University Memory Screen (SLUMS), and Mini Mental State Exam (MMSE). The study population will be persons with mild to moderate dementia identified by clinicians in standard care. From this population, subject participants will be randomized to intervention and control groups. Patients randomly assigned to the intervention group will be referred by their clinical providers to participate in V-CST, and those who accept the referral will participate in the intervention.

Interventions

  • BEHAVIORAL Referral for Cognitive Stimulation Therapy
  • OTHER No change to Standard of Care

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2023-04-10
Est. Completion 2025-06-12
Phase NA

What the Registry Record Tells You About NCT05860127

The ClinicalTrials.gov registry entry for NCT05860127 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Amherst, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Referral for Cognitive Stimulation Therapy is the first listed.

NCT05860127 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05860127 about?

NCT05860127 is a clinical study titled "Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial". Cognitive Stimulation Therapy (CST) is an evidence-based non-pharmacological group therapy shown to benefit people with mild to moderate dementia. Despite increasing availability of CST worldwide, access remains limited in the United States. This pilot pragmatic trial will embed CST referral into th...

What is the current status of trial NCT05860127?

This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2023-04-10. Estimated completion is 2025-06-12.

What interventions are being tested in trial NCT05860127?

The interventions under investigation include: Referral for Cognitive Stimulation Therapy (BEHAVIORAL), No change to Standard of Care (OTHER).

Who is sponsoring clinical trial NCT05860127?

This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.